1. Home
  2. BDSX vs BNTC Comparison

BDSX vs BNTC Comparison

Compare BDSX & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Biodesix Inc.

BDSX

Biodesix Inc.

HOLD

Current Price

$23.46

Market Cap

276.2M

Sector

Health Care

ML Signal

HOLD

Logo Benitec Biopharma Inc.

BNTC

Benitec Biopharma Inc.

HOLD

Current Price

$8.35

Market Cap

313.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BDSX
BNTC
Founded
2005
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Precision Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
276.2M
313.9M
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
BDSX
BNTC
Price
$23.46
$8.35
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
7
Target Price
★ $39.00
$24.33
AVG Volume (30 Days)
93.2K
★ 184.0K
Earning Date
11-02-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 6.67
EPS
N/A
★ N/A
Revenue
★ $88,499,000.00
N/A
Revenue This Year
$26.51
N/A
Revenue Next Year
$20.25
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 24.08
N/A
52 Week Low
$5.26
$8.06
52 Week High
$31.97
$16.76

Technical Indicators

Market Signals
Indicator
BDSX
BNTC
Relative Strength Index (RSI) 39.96 35.59
Support Level $19.26 $8.52
Resistance Level $24.82 $14.09
Average True Range (ATR) 1.88 0.62
MACD -0.55 0.01
Stochastic Oscillator 18.99 25.20

Price Performance

Historical Comparison
BDSX
BNTC

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus on lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources: providing diagnostic testing services associated with blood-based lung and COVID tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties, as well as the development and commercialization of companion diagnostics.

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on advancing novel genetic medicines. Its technology could provide a one-shot cure for a wide range of diseases that require strict, ongoing treatment regimens or have no effective treatment or only palliative care options. The Company is developing a silence-and-replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life-threatening genetic disorder. The company has a single operating segment, which is the business of discovery and development of therapeutic agents for the treatment of genetic disorders.

Share on Social Networks: